The Pathophysiology and Pharmacotherapy of Myocardial Infarction
- ISBN-10
- 1483277143
- ISBN-13
- 9781483277141
- Category
- Health & Fitness
- Pages
- 402
- Language
- English
- Published
- 2013-10-22
- Publisher
- Elsevier
- Authors
- Nabil El-Sherif, C. V. Ramana Reddy
Description
The Pathophysiology and Pharmacotherapy of Myocardial Infarction deals with the advances in the pathophysiology and pharmacotherapy of acute myocardial infarction and related complications. This book covers two major consequences—cardiac muscle dysfunction and cardiac electrical dysfunction. This text begins by reviewing the controversy surrounding the pathogenetic mechanisms of atheroma formation and its potential reversibility, including the status of coronary risk factors and benefits of primary prevention. The pathophysiologic mechanisms of pump failure and the current approach to its management are then deliberated, followed by a discussion on the rational use of vasodilators in post-infarction heart failure and pharmacotherapy of cardiogenic shock. The rationale for the interest in the role of coronary vasospasm and thrombolytic therapy for acute myocardial infarction is also covered. This publication concludes by reviewing the approaches for the management of post-infarction ventricular tachyarrhythmias and concept of secondary prevention of sudden cardiac death. This compilation is valuable to medical students, primary care physicians, and cardiovascular specialists.
Get the book
Similar books
-
Pathophysiology and Pharmacotherapy of Cardiovascular Disease
By Gowraganahalli Jagadeesh, Pitchai Balakumar, Khin Maung-UThe present book covers the basic principles of cardiovascular physiology, pathophysiology and advanced pharmacology with particular emphasis on cellular mechanisms of drug action.
-
Myocardial Infarction: A Companion to Braunwald's Heart Disease
By David A. MorrowComplemented by: Braunwald's heart disease.
-
Congestive Heart Failure: Pathophysiology, Diagnosis and Treatment
By Jon D. Blumenfeld, John H. Laragh28. Feelisch M , Noack E : The in - vitro metabolism of nitrovasodilators and their conversion into vasoactive species . In : Heart Failure : Mechanisms and Management . Lewis BS ( ed ) . Berlin : Springer - Verlag , 1991 ; 241-255 .
-
Cardiac Problems in Pregnancy
By Uri ElkayamFeaturing 36 new or extensively revised chapters, this fourth edition of the book complements coverage of the latest research and clinical advances with a complete and up-to-date bibliography of literature on pregnancy in women with ...
-
Translational Research in Coronary Artery Disease: Pathophysiology to Treatment
By Wilbert S. Aronow, John Arthur McClungProvides a concise summary of recent developments in coronary and vascular research, including previously unpublished data Summarizes in-depth discussions of the pathobiology and novel treatment strategies for coronary artery disease ...
-
Acute Heart Failure
By Joseph E. Parrillo, Alexandre Mebazaa, Mihai GheorghiadeBecause cardiologists and intensivists do not see the same patients and/or do not have the same background, this book represents a joint effort from internationally known cardiologists and intensivists to set up a single reference resource, ...
-
Coronary Heart Disease: Clinical, Pathological, Imaging, and Molecular Profiles
By Robert F. Wilson, Zeev Vlodaver, Daniel GarryWith contributions from a diverse group of internationally-known physicians with broad experience in the diagnosis and treatment of coronary heart disease, this book will be a valuable resource for practitioners in clinical cardiology, ...
-
Coronary Microvascular Dysfunction
By Filippo Crea, Gaetano A. Lanza, Paolo G. CamiciThis book provides an update on coronary physiology and a systematic assessment of microvascular abnormalities in cardiovascular diseases, in the hope that it will assist clinicians in prevention, detection and management of CMD in their ...
-
Bioresorbable Scaffolds: From Basic Concept to Clinical Applications
By Yoshinobu Onuma, Patrick W.J.C. SerruysThis book focuses on the coronary bioresorbable scaffold, a new interventional treatment for coronary artery disease, differentiated from a permanent metallic stent.
-
Cardioprotection
By Derek Hausenloy, Derek YellonCoronary heart disease (CHD) is the leading cause of death worldwide. Cardioprotection refers to the prevention of CHD and the clinical improvement in patients suffering from cardiovascular problems.